Chemistry researchers’ start-up takes aim at triple-negative breast cancer – without chemo side effects
Triple negative breast cancer (TNBC) is one of the most aggressive forms of breast cancer, and it does not respond to any of the hormone therapies designed to treat other types of breast cancer. Instead, the first line of defense …














